Title: Anirban Kundu - Innovator in Genetic Modification
Introduction: Anirban Kundu is an inventor based in West Palm Beach, FL (US). He is currently associated with Exuma Biotech Corp., where he focuses on advancements in genetic modification technologies. Despite having no granted patents to his name, Kundu is actively involved in innovative research that has the potential to impact the field of biotechnology significantly.
Latest Patent Applications: Anirban Kundu's notable patent application is titled "Methods and Compositions for Genetically Modifying and Expanding Lymphocytes and Regulating the Activity Thereof." This application outlines methods and compositions for genetically modifying lymphocytes, including T cells and NK cells. The methods utilize replication incompetent recombinant retroviral particles that may include a pseudotyping element and a membrane-bound T cell activation element, such as anti-CD3. The application details various exemplary time periods for contacting PBMCs with these particles, emphasizing the efficiency of the methods in modifying lymphocytes in whole blood or its components.
Conclusion: Anirban Kundu's work at Exuma Biotech Corp. showcases his commitment to advancing genetic modification techniques, which could lead to significant breakthroughs in biotechnology. His innovative approach and research efforts highlight the importance of continued exploration in this vital field.